← All trials
NCT04522622
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2020
- Primary completion
- Mar 31, 2024
- Completion date
- Mar 31, 2025
- First posted
- Aug 21, 2020
- Last posted
- Aug 21, 2020
- Enrollment
- 66
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of CopenhagenLead sponsor
- Steno Diabetes Center CopenhagenCollaborator
- University of CopenhagenSponsor investigator
- University of Southern DenmarkCollaborator
- University of AntwerpCollaborator
- University of CopenhagenCollaborator
- University of CopenhagenOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.